Skip to main content
Top
Published in: Pediatric Nephrology 3/2022

01-03-2022 | Chronic Kidney Disease | Editorial Commentary

Still trouble with serum creatinine measurements

Authors: Alexandra Kowalczyk, Maria Esther Diaz-Gonzalez de Ferris, Guido Filler

Published in: Pediatric Nephrology | Issue 3/2022

Login to get access

Excerpt

Utilizing serum creatinine to calculate the estimated glomerular filtration rate (eGFR) is a vital tool in classifying chronic kidney disease (CKD) stages and demands correct measurement. The study in this issue of Pediatric Nephrology, titled “Large Inter-assay Difference of Serum Creatinine in the Pediatric Population: a Threat to Accurate Staging of Chronic Kidney Disease,” addresses an important concern regarding limitations of precise creatinine measurement in a pediatric sample from Beaumont Health, Royal Oak, MI, USA. In pediatric populations, there are multiple factors which contribute to lower serum creatinine levels, including lower muscle mass overall and increased levels of non-creatinine chromogens, such as bilirubin [1]. Calibration procedures, which are traceable to isotope dilution mass spectroscopy (IDMS), allow standardization of serum creatinine levels [2]. The creation of reference materials is valuable and efforts to create standardized tools should be applauded. Unfortunately, there remains a paucity of reference materials that incorporate the much lower creatinine concentrations commonly seen in children. …
Literature
1.
go back to reference Filler G, Yasin A, Medeiros M (2014) Methods of assessing renal function. Pediatr Nephrol 29:183–192CrossRef Filler G, Yasin A, Medeiros M (2014) Methods of assessing renal function. Pediatr Nephrol 29:183–192CrossRef
2.
go back to reference Srivastava T, Alon US, Althahabi R, Garg U (2009) Impact of standardization of creatinine methodology on the assessment of glomerular filtration rate in children. Pediatr Res 65:113–116CrossRef Srivastava T, Alon US, Althahabi R, Garg U (2009) Impact of standardization of creatinine methodology on the assessment of glomerular filtration rate in children. Pediatr Res 65:113–116CrossRef
4.
go back to reference Pham-Huy A, Leonard M, Lepage N, Halton J, Filler G (2003) Measuring glomerular filtration rate with cystatin C and Œ≤-trace protein in children with spina bifida. J Urol 169:2312–2315CrossRef Pham-Huy A, Leonard M, Lepage N, Halton J, Filler G (2003) Measuring glomerular filtration rate with cystatin C and Œ≤-trace protein in children with spina bifida. J Urol 169:2312–2315CrossRef
5.
go back to reference Morgan C, Senthilselvan A, Bamforth F, Hoskinson M, Gowrishankar M (2008) Correlation between cystatin C- and renal scan-determined glomerular filtration rate in children with spina bifida. Pediatr Nephrol 23:329–332CrossRef Morgan C, Senthilselvan A, Bamforth F, Hoskinson M, Gowrishankar M (2008) Correlation between cystatin C- and renal scan-determined glomerular filtration rate in children with spina bifida. Pediatr Nephrol 23:329–332CrossRef
6.
go back to reference Filler G, Lee M (2018) Educational review: measurement of GFR in special populations. Pediatr Nephrol 33:2037–2046CrossRef Filler G, Lee M (2018) Educational review: measurement of GFR in special populations. Pediatr Nephrol 33:2037–2046CrossRef
7.
go back to reference Filler G, Lepage N (2003) Should the Schwartz formula for estimation of GFR be replaced by cystatin C formula? Pediatr Nephrol 18:981–985CrossRef Filler G, Lepage N (2003) Should the Schwartz formula for estimation of GFR be replaced by cystatin C formula? Pediatr Nephrol 18:981–985CrossRef
8.
go back to reference Filler G, Bökenkamp A, Hofmann W, Le Bricon T, Martínez-Brú C, Grubb A (2005) Cystatin C as a marker of GFR - History, indications, and future research. Clin Biochem 38:1–8CrossRef Filler G, Bökenkamp A, Hofmann W, Le Bricon T, Martínez-Brú C, Grubb A (2005) Cystatin C as a marker of GFR - History, indications, and future research. Clin Biochem 38:1–8CrossRef
9.
go back to reference Ismail OZ, Bhayana V, Kadour M, Lepage N, Gowrishankar M, Filler G (2017) Improving the translation of novel biomarkers to clinical practice: the story of cystatin C implementation in Canada: a professional practice column. Clin Biochem 50:380–384CrossRef Ismail OZ, Bhayana V, Kadour M, Lepage N, Gowrishankar M, Filler G (2017) Improving the translation of novel biomarkers to clinical practice: the story of cystatin C implementation in Canada: a professional practice column. Clin Biochem 50:380–384CrossRef
10.
go back to reference Pierce CB, Munoz A, Ng DK, Warady BA, Furth SL, Schwartz GJ (2021) Age- and sex-dependent clinical equations to estimate glomerular filtration rates in children and young adults with chronic kidney disease. Kidney Int 99:948–956CrossRef Pierce CB, Munoz A, Ng DK, Warady BA, Furth SL, Schwartz GJ (2021) Age- and sex-dependent clinical equations to estimate glomerular filtration rates in children and young adults with chronic kidney disease. Kidney Int 99:948–956CrossRef
11.
go back to reference Grubb A, Blirup-Jensen S, Lindstrom V, Schmidt C, Althaus H, Zegers I, IFCC Working Group on Standardisation of Cystatin C (WG-SCC) (2010) First certified reference material for cystatin C in human serum ERM-DA471/IFCC. Clin Chem Lab Med 48:1619–1621CrossRef Grubb A, Blirup-Jensen S, Lindstrom V, Schmidt C, Althaus H, Zegers I, IFCC Working Group on Standardisation of Cystatin C (WG-SCC) (2010) First certified reference material for cystatin C in human serum ERM-DA471/IFCC. Clin Chem Lab Med 48:1619–1621CrossRef
12.
go back to reference Sukhang M, Junkuy A, Buckley N, Mohamed F, Wunnapuk K (2020) An LC-MS/MS method for creatine and creatinine analysis in paraquat-intoxicated patients. J Environ Sci Health B 55:273–282CrossRef Sukhang M, Junkuy A, Buckley N, Mohamed F, Wunnapuk K (2020) An LC-MS/MS method for creatine and creatinine analysis in paraquat-intoxicated patients. J Environ Sci Health B 55:273–282CrossRef
13.
go back to reference Filler G, Bhayana V, Schott C, Díaz-González de Ferris ME (2021) How should we assess renal function in neonates and infants? Acta Paediatr 110:773–780CrossRef Filler G, Bhayana V, Schott C, Díaz-González de Ferris ME (2021) How should we assess renal function in neonates and infants? Acta Paediatr 110:773–780CrossRef
14.
go back to reference Filler G, Kirpalani A, Urquhart BL (2015) Handling of drugs in children with abnormal renal function. In: Avner ED, Harmon WE, Niaudet P, Yoshikawa N, Emma F, Goldstein S (eds) Pediatr Nephrol. Springer, Berlin Heidelberg, pp 1–28 Filler G, Kirpalani A, Urquhart BL (2015) Handling of drugs in children with abnormal renal function. In: Avner ED, Harmon WE, Niaudet P, Yoshikawa N, Emma F, Goldstein S (eds) Pediatr Nephrol. Springer, Berlin Heidelberg, pp 1–28
Metadata
Title
Still trouble with serum creatinine measurements
Authors
Alexandra Kowalczyk
Maria Esther Diaz-Gonzalez de Ferris
Guido Filler
Publication date
01-03-2022
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Nephrology / Issue 3/2022
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-021-05387-z

Other articles of this Issue 3/2022

Pediatric Nephrology 3/2022 Go to the issue